mark jenkins phd

• Our Providers

G. Mark Jenkins, MD, FACC

President, CVIG

Dr. Jenkins is an internationally recognized Interventional Cardiologist. He is President of The Cardiac and Vascular Interventional Group. He was listed as one of the top physicians in Texas and by Black Enterprise Magazine as one of the top 100 best physicians in the U.S.

His work at the  National Institutes of Health  and  Johns Hopkins Hospital  has been heralded as one of the top advancements in the treatment of coronary artery disease. Dr. Jenkins and his laboratory did the entire initial work that led to the development of the Paclitaxel Coated Drug Delivery Stent. The use patent for Paclitaxel’s use on stents for in-stent restenosis is held by his NIH lab. This patent was commercialized by Angiotech and sold to Cook Medical and Boston Scientific. This historic occurrence served as the basis for the development of one of the first drug eluting stents in the United States by Boston Scientific. Additionally, his lab at the National Institutes of Health published the initial papers in JCI & Circulation on the use of Paclitaxel in cell cultures and animal models. Dr. Jenkins was amongst the first experts to give talks in the United States on the use of Paclitaxel to address stent restenosis.

He is a past Advisory Board Member of Boston Scientific Corporation, Bard Corporation (now BD), and Abbott Vascular. He was formerly a board member of the Association of Black Cardiologist, Inc, where he was the longest-serving Board Member. He served, previously, as the Director of the Methodist Dallas Heart and Vascular Clinic. His input is often sought out by various medical device companies in need of his consultation for medical devices in development. He has spoken at the national sales meetings of both Boston Scientific and Abbott Vascular. He has also spoken at the Fritz-Pollard Alliance Foundation Super Bowl event on several occasions to educate the NFL commissioner, team owners, team executives, and athletes on sudden cardiac death.

Dr. Jenkins is a founding committee member of Boston Scientific’s “Close The Gap” national disparity campaign. He is a founding committee member of Bard Corporation’s (now BD) “Love Your Limbs” national Peripheral Artery Disease (PAD) awareness campaign.

After graduating valedictorian of his high school, he attended college at  Brown University in Providence, Rhode Island where he also graduated with honors. Dr Jenkins continued his education by attending medical school at  Johns Hopkins School of Medicine.   He completed his internship and residency in Internal medicine, and his fellowship in cardiology and interventional cardiology at the John Hopkins Hospital. He spent 4 years at NIH as a Senior Research Associate in basic vascular biology research.

Dr. Jenkins’s areas of interest include cardiac consultation, performance of coronary intervention including balloon angioplasty, stenting, intravascular ultrasound, laser atherectomy, rotablation and the performance of peripheral interventions including arteriograms, IVUS, balloon angioplasty, stenting laser atherectomy, digital orbital atherectomy and cryoplasty for the treatment of renal arterial disease and peripheral vascular disease involving lower extremities.

Among his many academic achievements, Dr. Jenkins has authored numerous peer-reviewed articles in major journals.

In his spare time he enjoys playing the piano and spending time with friends and family. He is also an Eagle Scout.

Brown University Biochemistry, AB

Johns Hopkins School of Medicine Doctorate of Medicine, MD

Johns Hopkins Hospital Internal Medicine Intern & Residency

Johns Hopkins Hospital Cardiovascular Disease Fellowship

Johns Hopkins Hospital Interventional Cardiology Fellowship

National Institute of Health Clinical Research Scientist

Plan Your Visit

425 S Llewellyn Ave, Dallas, Texas 75208, US

(214) 946-7445

• -- mi Dallas
• -- mi DeSoto
• Admin Log In
• Privacy Policy

• Agriculture & Environment
• Architecture & Design
• Arts & Humanities
• Business & Management
• Campus Affairs
• Law & Policy
• Science & Technology
• Social Sciences
• Sports & Recreation
• Story Archive
• For Journalists

Marc Jenkins

Distinguished McKnight University Professor

Director, Center for Immunology

Introduction

Marc K. Jenkins, Ph.D., is a professor at the University of Minnesota Medical School.

Jenkins and his colleagues investigate CD4+ T and B cell activation in vivo by directly tracking antigen-specific cells. The goal of this research is a basic understanding of lymphocyte activation that can be used to improve vaccines and prevent autoimmunity.

Jenkins is director of the Center for Immunology, an interdisciplinary unit at the University of Minnesota Medical School devoted to advancing the field of immunology and educating future immunologists. 

News about Marc Jenkins

Two U of M faculty elected to the National Academy of Sciences

Members elected in recognition of their distinguished and continuing achievements in original research.

Search all experts

Marc Jenkins, PhD

Regents and distinguished mcknight university professor in the department of microbiology and immunology director of the center for immunology at the university of minnesota.

Marc Jenkins, PhD, is the Regents and Distinguished McKnight University Professor in the Department of Microbiology and Immunology and Director of the Center for Immunology at the University of Minnesota. He studies CD4+ T lymphocytes and the signals that these cells need to become activated by antigens, where in the body activation occurs, and how activation results in immune memory.

Dr Jenkins is a past President of the American Association of Immunologists and a recipient of the Mentoring and Lifetime Achievement Awards from that organization. He was elected to the National Academy of Sciences in 2020.

Privacy Overview

• be_ixf; php_sdk; php_sdk_1.4.26
• https://www.evangel.edu/faculty/mark-jenkins/

Mark Jenkins, Ph.D.

Trask 214, suite B, Theology Department | [email protected]

Due to inclement weather, EU will be closed Monday, Jan. 22.

Job Responsibilities: Teaching on both the main campus at Evangel University and also at the campus of James River Leadership College.

Org Memberships: The American Schools of Oriental Research The Society of Biblical Literature

Courses Taught: Essential Christianity Old Testament Literature Old Testament Historical Books New Testament Literature Biblical Hebrew Archaeology of Ancient Israel Archaeology of the New Testament World Anthropology Frameworks- Culture

Started Work: Faculty at CBC, beginning in 2003 Faculty at Evangel University beginning in 2013.

Favorite Thing About Work: Being in the classroom is my favorite thing about being a professor at Evangel. There is no greater fulfillment than to influence the lives of students who will go on to be tomorrows leaders.

Was an Evangel Student: 1981-1985

Favorite Memory as a Student: My favorite memories at Evangel are associated with playing varstiy football and the enduring friendships that were a result.

Originally From: San Diego, CA

Personal Information: My wife and I are graduates of Evangel. She currently teaches classes in the Social Work department. My passion is Biblical Archaeolgy. I am currently digging at Gath, the home of Goliath. You are welcome to participate, ask me how!

• MyU : For Students, Faculty, and Staff

Considered to be one of the countries high performing medical school, the University of Minnesota believes that promoting and rewarding a culture of excellence is key in maintaining high standards. One way of displaying specifically how we impact medicine is to showcase those who exemplify the mission. Dr. Marc Jenkins was showcased, in an interview about how he has sought and discovered answers about our world through science.

Dr. Marc Jenkins Seeks—and Discovers—Answers About Our World Through Science 

SEPTEMBER 30, 2019 UMN Medical School  

For a naturally curious person who enjoys finding answers with the scientific method, the University of Minnesota Medical School is the perfect place to work. Marc Jenkins, PhD, a Regents and Distinguished McKnight University Professor in the Medical School’s Department of Microbiology and Immunology, taps into his inquisitiveness to make discoveries about our immune system. 

Specifically, he has devoted his career to exploring CD4 lymphocytes, also called the helper T lymphocyte. Jenkins strives to understand how these cells respond to foreign substances like infections or tumors by producing an immune response to eliminate them from our bodies. That response should happen consistently and develop long-term immunity—the basis for vaccines. 

“A lot of my research relates to vaccines and why some work and some don’t,” says Jenkins, director of the Center for Immunology. “At a basic level, I’m trying to understand why this subset of lymphocyte evolved and how it becomes activated to recognize foreign entities.”

Jenkins’ work has real-world applications, such as the research on T cell co-stimulation and CD28 he did as a postdoctoral fellow at the National Institutes of Health and then at the University of Minnesota. Based on his findings, scientists developed CD28-targeted therapies for graft rejection and rheumatoid arthritis. 

“That discovery happened in the mid-1980s, and it took 20 years for the discovery to be applied to clinical medicine,” he says. “Eventually it was, and so I’m proud of that.”

Gaining Knowledge, Returning Home

A native of Minnesota, Jenkins earned a bachelor’s degree in microbiology from the College of Biological Sciences at the University of Minnesota before leaving to pursue a doctorate in microbiology and immunology from Northwestern University. After his NIH fellowship in 1988, Jenkins was thrilled to return to the University as an assistant professor of microbiology. It was a nice homecoming for Jenkins that renewed his appreciation for the Minnesota approach to work.

“There are really talented investigators here, and they are ambitious and accomplish a lot,” he says. “But students here are not going to be assigned to the same project as someone else to fight it out, and they’re not going to be afraid to share their results with other people in the community. We’re trying to make it fun to work hard.”

Honored for His Contributions

Jenkins has thrived at the University. In 2018, he received the Regents Professorship, one of the University’s highest honors that recognizes the national and international prominence of faculty and their exceptional contributions to teaching, research, scholarship, creative work and collaboration. He was also named a Distinguished McKnight professor earlier in his career. 

“They both mean a lot to me because they are recognition by my colleagues,” he adds. 

Jenkins also finds meaning in working with enthusiastic, smart students who keep him young. He calls his career too good to be true, thanks to his ability to seek answers to the many scientific questions that interest him. 

“I’m fortunate that I can follow my ideas as long as I can convince other people in the field that they are good ideas,” he says. “Then, I can chase my dreams.” __________________

For more information or stories, go to  Impact Medicine

• All CFI Alumni
• Binstadt Lab Alumni
• Bold Lab Alumni
• Farrar Lab Alumni
• Fife Lab Alumni
• Freedman Lab Alumni
• Hamilton-Hart Lab Alumni
• Hogquist Lab Alumni
• Jameson Lab Alumni
• Jenkins Lab Alumni
• Khoruts Lab Alumni
• Masopust Lab Alumni
• Mueller Lab Alumni
• Peterson Lab Alumni
• Shimizu Lab Alumni
• Stromnes Lab Alumni
• Vezys Lab Alumni
• Gillespie Lab Alumni
• Kaplan Lab Alumni
• Mescher Lab Alumni
• Current Graduate Students
• Current Postdoctoral Scholars
• Current Research Associates/Research Assistant Professors
• All CFI News
• 2015 Publications
• 2016 Publications
• 2017 Publications
• 2018 Publications
• 2019 Publications
• 2020 Publications
• 2021 Publications
• 2022 Publications
• 2023 Publications
• 2024 Publications
• CFI Wall of Honor
• CFI and UMN Collaborations
• Print Media
• Radio and TV
• 2014 Mescher Scholars
• 2015 Mescher Scholars
• 2016 Mescher Scholars
• 2017 Mescher Scholars
• 2018 Mescher Scholars
• 2019 Mescher Scholars
• 2021 Mescher Scholars
• 2022 Mescher Scholars
• 2023 Mescher Scholars
• New Employee Training
• Past Immunology Grant Trainees

• MyU : For Students, Faculty, and Staff

University Awards & Honors

Marc Jenkins

Regents professor.

Microbiology and Immunology, Medical School, 2018

Regents Professor Marc Jenkins, one of the world’s most distinguished immunologists, is a professor in the department of microbiology and immunology in the Medical School, the director of the University of Minnesota Center for Immunology, and a Distinguished McKnight University Professor. His groundbreaking research has advanced the entire field of immunology. His crucial contributions establish basic immunological principles for broadly solving human health problems, from developing more effective vaccines; to better treatments for autoimmune diseases such as rheumatoid arthritis and diabetes; to improved success in transplantation and cancer immunotherapy. Jenkins’ career has been devoted to understanding how particular lymphocytes, called CD4 T cells, orchestrate the entire immune response to pathogens and cancer cells.

The importance of Jenkins’ work is apparent in his citation record, invitations to lecture, and the awards he has received. His 170 plus papers to date have been cited over 18,000 times, earning him recognition by the Institute for Scientific Information as a highly-cited researcher in Immunology. Five of his papers have been cited over 500 times and two over 1,000 times. His work appears frequently in the top journals such as Cell, Nature, Science, Immunity, and Nature Immunology . He has also authored numerous chapters in books. Jenkins has been invited to give more than 450 research seminars in the U.S. and abroad, 35 of which were keynote or honorary lectures.

He is the recipient of many national research awards including the PEW Scholars Award, NIH MERIT Award, and the American Association of Immunologist’s Meritorious Career Award. From the University of Minnesota, he received a Distinguished McKnight University Professor award (2002), the Academic Health Center Academy for Excellence in Health Research Award (2004), the Medical School’s Senior Investigator Award (2011), and a Medical School Dean’s Distinguished Lectureship (2015).

Jenkins is an outstanding teacher and mentor. He was instrumental in the creation of what is now known as the Microbiology, Immunology and Cancer Biology PhD program and served as its first director of Graduate Studies. He received the University’s award for Outstanding Contributions to Post-Baccalaureate Graduate and Professional Education (2003) for establishing the program’s national reputation as a “premiere training environment in biomedical research.” He has been a mentor to 17 doctoral students and 24 postdoctoral fellows. Jenkins was awarded the 2018 American Association of Immunologist’s Excellence in Mentoring Award, which is given annually to one of the organization’s members who has profoundly influenced the lives of many people; in this case, his many predoctoral and postdoctoral trainees. He also serves as a mentor and advisor to many of his faculty colleagues and received the Carole J. Bland Outstanding Faculty Mentoring Award for his efforts in this area.

His service in and outside of the University is also exceptional. On the national level, he served as president of the American Association of Immunologists and as a member on the Scientific Advisory Boards of the PEW Scholars Program and the National Cancer Institute. At the University level, Jenkins has served as a faculty senator, a member of the Medical School Research Council, chair of the AHC Faculty Consultative Committee, co-chair of the Strategic Positioning Research Infrastructure Task Force, and chair of the Medical School Research Space Utilization Committee. At the community level, he served as an elected member of the Richfield School Board.

Professor Jenkins has proven to be an eminent representative of the University of Minnesota and exemplifies the qualities of a Regents Professor in all respects

Biographies are as-of time of award presentation.

• Current Faculty
• Current Students
• Current Employees
• Retired Employees
• Associated with Gifts or Sponsorship
• College & School Awards
• System Campus Awards

Marc K. Jenkins, Ph.D.

 Brief Bio

 oral history - full interview.

Interview Date: Friday, May 10, 2019 Location: San Diego, CA

Click here to see other interviews from the Oral History Project

 Oral History - Transcript

 aai service history,  president's address.

The Journal of Immunology  193, no. 8 (2014): 3829-31.

 President's Message

AAI Newsletter  (October, 2013) 3–4.

 Awards and Honors

• Meritorious Career Award , AAI, 2002
• NIH NIAID Merit Award, 2008
• Senior Investigator Award, University of Minnesota Medical School, 2011
• Excellence in Mentoring Award , AAI, 2018
• Distinguished Fellow , AAI, 2019
• Lifetime Achievement Award , 2020
• National Academy of Sciences, Member, 2020
• Lifetime Achievement Award , AAI, 2020

 Institutional/Biographical Links

• Marc K. Jenkins University of Minnesota  faculty page
• Marc Jenkins Lab , University of Minnesota
• History Articles
• Oral History
• History of Immunology and Science Timeline
• Nobel Laureates
• Lasker Awardees
• Distinguished Scientific Awards
• AAAS Fellows
• NAS Electees
• In Memoriam
• Past Presidents and Officers
• Past Presidents' Messages
• History Projects

• Marc K. Jenkins, Ph.D.
• Directory of Scholars
• Program Details

Our laboratory is dedicated to unraveling the cellular and molecular interactions that dictate the function of this lymphocyte subset in the body. This has been challenging because the helper T cells that are specific for a particular peptide:MHCII ligand are extremely rare in the total T cell population. To circumvent this problem, we developed a technique whereby a small number of monoclonal CD4+ T cells specific for a single peptide:MHCII ligand are transferred into a normal mouse. Tracking this population of T cells using flow cytometry and confocal microscopy has allowed us to visualize and identify the roles of various antigen-presenting cells, costimulatory receptors, and lymphokines during the early phases of the helper T cell response.

We recently developed a method based on peptide:MHCII tetramers and magnetic bead enrichment that has the sensitivity to detect individual peptide:MHCII-specific T cells in unmanipulated mice. This powerful technique circumvents the caveat that adoptive transfer of monoclonal T cells may not always accurately reflect the true in vivo behavior of helper T cells. We have found that the size of the initial naive repertoire for individual CD4+ antigen specific T cells varies widely from antigen to antigen and that this initial population size ultimately predicts the magnitude of the response.

Our current research is aimed at using these tools to gain insight into T cell development, activation, and memory in the mouse to set the stage for similar studies in humans. Our hope is that this basic knowledge will ultimately be used to improve vaccines and prevent unwelcome T cell responses such as autoimmunity and graft rejection.

Search Pew Scholars

Scholar keywords.

• Antigen presenting cells
• Helper T cells
• Lymphocytes
• MHCII tetramers

1989 Search Pew Scholars

• Michael P. Bevilacqua, M.D., Ph.D.
• Pamela J. Bjorkman, Ph.D.
• Anthony M.C. Brown, Ph.D.
• Nancy Carrasco, M.D.
• Gregory A. Clark, Ph.D.
• Pamela Cowin, Ph.D.
• Douglas W. DeSimone, Ph.D.
• Daniel D. Kalderon, Ph.D.
• Bruce D. Kohorn, Ph.D.
• J. Michael Koomey, Ph.D.
• John Kuriyan, Ph.D.
• Richard S. Lemons, M.D., Ph.D.
• Marla B. Luskin, Ph.D.
• Susan K. McConnell, Ph.D.
• Virginia L. Miller, Ph.D.
• M. Bishr Omary, M.D., Ph.D.
• Hermann Steller, Ph.D.
• John B. Thomas, Ph.D.
• Wesley C. Van Voorhis, M.D., Ph.D.

Mark Jenkins

Research interests.

• Advanced Search
• Online Activities
• Live Events
• While browsing CECentral, you can 'save' activities of interest by clicking on the little diskette icon located near the title of any given activity throughout the site. "> Saved Activities (   )

Mark Jenkins

Send me the catalogue, request catalog.

Mark Jenkins (1970, Virginia, USA)  is internationally well-known for his street interventions , in particular for his extraordinary sculptures which have populated cities throughout the world. An urban stage which hits the passer-by , sculptures placed in uncommon situations and positions , embedded into the space of everyday life creating a surreal and enigmatic landscape . 

Mark Jenkins: art

Using transparent tape as casting material to reproduce human figures and objects, the artist places his works where they can create an impact on people. For this reason, he considers the street as a stage , and its regulars are unconscious actors whose reactions are documented. The peculiarity rolex replica in his work is the unavoidable and essential relationship established between artist and audience . Thought-provoking, imaginative and grotesque in some cases, the site-specific works by Mark Jenkins give people a chance to react, and to reflect on social as well as political issues . 

Most important exhibitions

His work has been exhibited from New York to Barcelona, from Tokyo to Moscow .  Notable projects and exhibitions the artist has partaken in are: Mark Jenkins: Remix, Arsenal Contemporary Art (Montreal, 2016) , ‘Knock Knock’, Ruttkowski;68, (Cologne, 2016), Vitality and Verve in the Third Dimension (Collective exhibition), Long Beach Museum of Art (Long Beach, USA, 2016) and Ex Situ, Pompidou Centre (Paris, France, 2013). Mark Jenkins has also participated to festivals and art projects such as City Leaks (Cologne, Germany, 2013) , Bien Urbain (Besancon, France, 2013), White Walls (Beirut, Lebanon, 2013), Walk and Talk Festival (Azores, Portugal, 2013), Dublin Contemporary 2011 (Dublin, Ireland, 2011 ). He collaborated with Greenpeace in 2008 and curated Les Grandes Traversees festival in Bordeaux in 2010.

Related Exhibition

Related Post

• 10 September 2021
• Wunderkammern

• 13 January 2021

Official websites use .gov

Secure .gov websites use HTTPS

Ambassador Bonnie Denise Jenkins

Under Secretary for Arms Control and International Security

July 22, 2021 - Present

Ambassador Bonnie Jenkins, PhD, has served as the Under Secretary of State for Arms Control and International Security since July 22, 2021. As Under Secretary, she oversees three bureaus: the Arms Control, Deterrence and Stability Bureau; the International Security and Nonproliferation Bureau (ISN); and the Political-Military Affairs Bureau. In addition, as of May 2023, Secretary of State Antony Blinken named Under Secretary Jenkins as the senior official to lead the Department’s efforts on AUKUS implementation. Jenkins has the honor of being the first African American to serve as an Under Secretary of State.

U/S Jenkins previously served in the Obama Administration as Special Envoy and Coordinator for Threat Reduction Programs in the ISN bureau from July 2009 until January 2017. In that role, Ambassador Jenkins coordinated U.S. government efforts on threat reduction programs alongside international programs that prevent non-State actors with intent to do harm from acquiring chemical precursors, biological pathogens, nuclear material, and radiological sources to develop Weapons of Mass Destruction (WMD). She was also the State Department’s lead for all four of the Nuclear Security Summits held from 2010 to 2016, as well as the U.S. Representative to the G7 Global Partnership Against the Spread of Weapons and Materials of Mass Destruction.

From 2014 to 2017, Ambassador Jenkins led diplomatic efforts to promote the Global Health Security Agenda , a group of countries, international organizations, non-government organizations, and private sector companies that build countries’ capacity to prevent, detect, and respond to infectious disease threats. During that time, she established the Global Health Security Consortium and the Global Health Security Next Generation Network. As Coordinator, Jenkins also dedicated significant attention to the engagement with Africa to counter WMD threats. In partnership with the U.S. Defense Threat Reduction Agency and U.S. Africa Command, she co-developed the Threat Reduction in Africa program to help ensure that U.S. programs and activities in WMD security are well coordinated and meet the needs of African partners. She also Chaired the International Atomic Energy Agency’s International Network for Nuclear Security Training and Support Centers. For her service as Coordinator of Threat Reduction Programs, Ambassador Jenkins was the 2016 ISN Nominee for the Secretary of State’s Award for Excellence in International Security Affairs.

From its inception in 2017 until April 2021, Ambassador Jenkins was the Founder, Executive Director, and Board Chair of Women of Color Advancing Peace and Security (WCAPS) , a leading advocacy organization supporting women of color in the security and peace-building sector. In June 2020, she also founded Organizations in Solidarity , which supports a common vision of a world where all people are treated equally, fairly, and with respect. She also played a pivotal role in the founding of the International Career Advancement Program (ICAP) and has established several mentorship programs. Also, in 2020 – 2021, Jenkins served as the Chair of the Committee on Radioactive Sources: Applications and Alternative Technologies of the National Academies of Sciences.

From 2005 – 2009, Jenkins worked at the Ford Foundation as the Program Officer for U.S. Foreign and Security Policy, and on Conflicts. From 2003 – 2004, she served as Counsel on the National Commission on Terrorist Attacks Upon the United States (9/11 Commission). She was the lead staff member conducting research, interviews, and preparing commission reports on counterterrorism policies in the Office of the Secretary of Defense and on U.S. military plans targeting al Qaeda before 9/11. Prior to that, Ambassador Jenkins served as General Counsel to the U.S. Commission to Assess the Organization of the Federal Government to Combat the Proliferation of Weapons of Mass Destruction and worked at the Rand Corporation focusing on Middle East weapons of mass destruction issues.

From 1990 – 1998, U/S Jenkins was a Legal Adviser to the U.S. Arms Control and Disarmament Agency where she provided advice to U.S. ambassadors and delegations negotiating arms control, disarmament, and nonproliferation of weapons of mass destruction and conventional weapons treaties. Ambassador Jenkins also worked with the administration to achieve advice and consent to treaties and conventions and provided legal advice to related treaty implementation organizations.

Jenkins is a retired U.S. Naval Reserve Officer and has received numerous awards for her military service. From 2006 – 2007, she was called-up for active-duty support of Operation Enduring Freedom at U.S. Central Command where she was the team lead for WMD and Theater Ballistic Missile (TBM) Target Development Teams, and a Certified Target Developer. Jenkins also held leadership positions in the Interallied Confederation of Reserve Military Officers (CIOR).

Ambassador Jenkins has been an adjunct professor at Georgetown University Law School, Georgetown University School of Foreign Service, George Washington University Elliott School of International Affairs, the Frank Batten Schol of Leadership and Public Policy at the University of Virginia, The University of Texas at Austin Lyndon B. Johnson School of Public Affairs, and The University of Minnesota Hubert Humphrey School of Public Affairs. Jenkins assisted in designing and leading arms control and nonproliferation simulation courses at Stanford University and in designing simulations at the University of Pennsylvania and Spelman College.

From 2017 to 2020, Ambassador Jenkins was a Nonresident Senior Fellow at Brookings Institution. In 2017 she was a Senior Fellow at the Perry World House at the University of Pennsylvania and from 2018 – 2020 was a Visiting Scholar at the University of Pennsylvania School of Nursing and School of Veterinary Science. She was also a pre-doctoral fellow at the Belfer Center for Science and International Affairs at the John F. Kennedy School of Government, Harvard University. During her years at the Belfer Center, she also worked at Harvard Law School in the Bernard Koteen Office of Public Interest Advising as an advisor to law students on legal jobs in the public sector. Ambassador Jenkins has a Ph.D. in International Relations from the University of Virginia; an LL.M. in International and Comparative Law from the Georgetown University Law Center; an M.P.A. from the State University of New York at Albany; a J.D. from Albany Law School; and a B.A. from Amherst College. She also attended The Hague Academy for International Law and is a member of the New York State Bar.

In 2023, Jenkins became an Honorary Member of the Delta Sigma Theta Sorority.

U.S. Department of State

The lessons of 1989: freedom and our future.

Center for Immunology

Medical School

• COVID-19 Response
• Association of Immunologists for Racial Equity (AIRE, formerly ReJUS)
• Empowering Women in Science
• Upcoming Training and Discussion Seminars
• In Memoriam
• Join our faculty
• Current Graduate Students
• Graduate Student Funding
• UMN Postdoctoral Association
• International Travel Grants for Postdoctoral Scholars
• Prospective Post Doctorate Trainees
• Academic and Professional Development
• Funding Resources
• Research Associates / Research Assistant Professors
• Center for Autoimmune Disease Research
• New Employee Training
• Dirty Mouse Colony Core Facility
• Flow Cytometry Core
• Researcher Resources
• Wiley's Current Protocols
• Xray Irradiator
• Current Immunology Grant Trainees
• Past Immunology Grant Trainees
• Diversity Statement
• How to Apply
• News and Honors
• Past Publications (2015-2022)
• Wall of Honor
• Research Labs
• Undergraduate Research Opportunities
• Past Conferences
• Newsletters
• Immunology Journal Club and SuperGroup
• Previous Blumenthal Memorial Lectureship Speakers
• Previous MICaB Invited Speaker Seminar Series
• MICaB Student Seminar
• Paul Cleary Autoimmunity and Infection seminar
• R.E.D. Seminar Series
• Archived News

Autoimmunity • Cancer • Vaccines • Cures

The Center for Immunology is an interdisciplinary research program at the University of Minnesota devoted to advancing the field of immunology and educating future immunologists.

Considering graduate study in immunology? The University of Minnesota offers several graduate programs.

Explore education and training opportunities with the Center for Immunology.

CFI  Immunology Journal Club and CFI Event calendar .

CFI Director, Marc Jenkins, PhD 

Regents and Distinguished McKnight Professor in the Department of Microbiology and Immunology

The Center for Immunology at the University of Minnesota Medical School is driven to make discoveries about the immune system that improve human health and well-being.

MICaB Final Defense

Thursday, September 5, 2024

2-102 CMRR or Zoom 10:00 am

The Center for Immunology is excited to welcome back Dr.

Congratulations to Dr. Steve Jameson on his appointment as the President of the AAI for the 2024-2025 term! This is a significant achievement and a testament to his dedication and contributions to the field.

More CFI News

• CFI Tea Time: Monday & Wednesdays at 2:30pm, 2-163 WMBB
• RED Seminar Series Returns September 9, 2024!!
• Protocol Writing Program open for enrollment! The Medical School Office of Research is excited to share that Protocol Writing Program is officially open for enrollment in the Training Hub . It is open to all research staff, faculty, trainees, and research fellows. The program’s eight modules (plus two optional modules) allow learners to participate at their own pace and to leave/re-enter the course when learning best fits into their schedule. 
• Need Help Complying with the New NIH Data Management and Sharing Plan (DMSP) policy ? AAI Has Resources That Can Help. See:  https://bit.ly/3Dh0vPM  and  https://bit.ly/3XW49Gv . UMN Libraries and OVPR are collaborating to build additional guidance and support, the most important items to know are listed  here or check out the UMN Libraries'  Research Data Services (RDS) website .

44th Annual Meeting of The American Society for Reproductive Immunology

 Submit an Abstract                                     Travel/Award Applications  

MICaB/Immunology Invited Speaker Seminar

Special seminar 8/19/2024 12:00-1:00 p.m.|1-125 CCRB| Zoom

Returns September 9, 2024 9:00 - 10:00 a.m.|1-125 CCRB 

Click here for full schedule

Kristiansand, Norway

London, England

Montreal, Canada

Cologne, Germany

Besançon

Rio de Janeiro

Winston-Salem

Puerto del Rosario

Washington DC

Washington, DC

Ponta Delgada